Table 1.
Demographic and laboratory data of BA patients and control patients.
| Control (n = 8) | BA1 group (n = 16) | BA2 group (n = 14) | p-Value (BA1 vs. BA2) | |
|---|---|---|---|---|
| PREOPERATIVE DATA | ||||
| Operative age(day) | 992.9 ± 777.6 | 56.0 ± 11.3 | 56.9 ± 7.2 | >0.05 |
| Gender(F:M) | 5:3 | 10:6 | 9:5 | >0.05 |
| Weight(kg) | 13.1 ± 6.24 | 4.8 ± 0.5 | 4.6 ± 0.6 | >0.05 |
| PLT | 237.3 ± 92.4 | 356.7 ± 194.8 | 328.6 ± 105.0 | >0.05 |
| GGT | — | 675.3 ± 439.0 | 633.9 ± 471.6 | >0.05 |
| AST(U/L) | 101.9 ± 137.8 | 245.9 ± 181.3 | 144.5 ± 89.5 | >0.05 |
| ALT(U/L) | 88.1 ± 99.8 | 112.8 ± 75.4 | 102.1 ± 53.4 | >0.05 |
| TB(μmol/L) | 85.3 ± 91.2 | 162.3 ± 43.5 | 145.5 ± 67.9 | >0.05 |
| DB(μmol/L) | 55.1 ± 56.7 | 110.1 ± 33.4 | 99.6 ± 18.9 | >0.05 |
| SIX MONTHS AFTER SURGERY | ||||
| AST(U/L) | 45.1 ± 52.7 | 41.6 ± 9.6 | 188.4 ± 156.3 | <0.05 |
| ALT(U/L) | 38.5 ± 52.0 | 31.8 ± 17.3 | 168.7 ± 138.2 | <0.05 |
| TB(μmol/L) | 14.1 ± 16.9 | 7.3 ± 2.5 | 90.9 ± 67.9 | <0.05 |
| DB(μmol/L) | 8.5 ± 12.9 | 2.1 ± 0.9 | 72.1 ± 59.7 | <0.05 |
| Follow-up(month) | — | 19.1 ± 5.8 | 8.6 ± 4.0 | <0.05 |
| AT SIXTH MONTH AFTER SURGERY | ||||
| TB(μmol/L) | — | 7.6 ± 5.1 | 91.4 ± 69.6 | <0.05 |
| DB(μmol/L) | — | 3.8 ± 4.1 | 73.5 ± 60.2 | <0.05 |
Data were shown as the mean ± standard error (SEM).
M, male; F, female; PLT, Platelets; GGT, gamma-glutamyl transpeptidase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; DB, direct bilirubin; TB, total bilirubin; control, choledochal cyst; BA1, good prognosis; BA2, poor prognosis.